Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Benedikt Obermaier"'
Autor:
Oliver T. Fackler, Iart Luca Shytaj, Nadine Tibroni, Marina Lusic, Ricardo Sobhie Diaz, Swetha Ananth, Benedikt Obermaier, Virginia Pierini
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 85(2)
Autor:
Oliver T. Fackler, Nadine Tibroni, Bettina Stolp, Benedikt Obermaier, Swetha Ananth, Iart Luca Shytaj, Katharina Morath, Marina Lusic, Birthe Trautz
Publikováno v:
Journal of Virology. 94
HIV-1 Nef promotes virus spread and disease progression by altering host cell transport and signaling processes through interaction with multiple host cell proteins. The N-terminal region in HIV-1 Nef encompassing residues 12 to 39 has been implicate
Autor:
Benedikt Obermaier, Annika Welchar, Lioba Klaas, Vinona Wicht, Michael Hosch, Marie Louise Aicher, Richard Dodel
Publikováno v:
InFo Neurologie & Psychiatrie. 19:36-44
Fur die Therapie der Demenz vom Alzheimer-Typ befinden sich einige krankheitsmodifizierende Medikamente in der klinischen Entwicklung. Die Kosten hierfur sind jedoch hoch und die Entwicklung ist langwierig. Trotzdem sehen einige Forscher reale Chance
Autor:
Swetha, Ananth, Katharina, Morath, Birthe, Trautz, Nadine, Tibroni, Iart Luca, Shytaj, Benedikt, Obermaier, Bettina, Stolp, Marina, Lusic, Oliver T, Fackler
Publikováno v:
J Virol
HIV-1 Nef promotes virus spread and disease progression by altering host cell transport and signaling processes through interaction with multiple host cell proteins. The N-terminal region in HIV-1 Nef encompassing residues 12 to 39 has been implicate
Autor:
Andrea Savarino, Oliver T. Fackler, Ermelindo Della Libera, James Hunter, Danilo Rocha Dias, Iart Luca Shytaj, Juliana Galinskas, Benedikt Obermaier, Mario Janini, Paulo Roberto Abrão Ferreira, Juliana Terzi Maricato, Ricardo Sobhie Diaz, Leila B. Giron, Maria Cecília Araripe Sucupira, Marina Lusic, Gisele Cristina Gosuen
Publikováno v:
International journal of antimicrobial agents. 54(5)
Antiretroviral therapy (ART) is typically composed of a combination of three antiretroviral drugs and is the treatment of choice for people with human immunodeficiency virus type 1/acquired immune deficiency syndrome (HIV-1/AIDS). However, it is unab